Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Bernstein

Showing results (221-230 of 698) with videos related to

Pageof 70
Sort By:
Allergy and Asthma Proceedings|March 25, 2015
Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedemaKonrad Bork, Timothy J Craig, Jonathan A Bernstein, et al.
Allergy|December 16, 2020
Treatment of chronic spontaneous urticaria with benralizumab: Report of primary endpoint per-protocol analysis and exploratory endpointsJonathan A Bernstein, Umesh Singh, Marepalli B Rao, et al.
Clinical Therapeutics|March 26, 2014
The effect of weight on the efficacy and safety of C1 esterase inhibitor concentrate for the treatment of acute hereditary angioedemaJonathan A Bernstein, Thomas Machnig, Heinz-Otto Keinecke, et al.
Case Reports in Psychiatry|July 28, 2018
An Atypical Presentation of Pediatric Acute Neuropsychiatric Syndrome Responding to Plasmapheresis TreatmentDrew H Barzman, Hannah Jackson, Umesh Singh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2013
Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacksTimothy J Craig, Mikhail A Rojavin, Thomas Machnig, et al.
The New England Journal of Medicine|September 30, 2020
Benralizumab for Chronic Spontaneous UrticariaJonathan A Bernstein, Umesh Singh, Marepalli B Rao, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 7, 2024
Real-world unified airway benefits of mepolizumab: Effectiveness in patients with asthma and comorbid nasal polypsJonathan A Bernstein, Jared Silver, Elizabeth Packnett, et al.
Current Allergy and Asthma Reports|January 24, 2022
Current Needs Assessment for Using Lung Clearance Index for Asthma in Clinical PracticeIvan Cherrez-Ojeda, K Robles-Velasco, María F Osorio, et al.
Addictive Behaviors|August 10, 2016
Evaluation of smokers with and without asthma in terms of smoking cessation outcome, nicotine withdrawal symptoms, and craving: Findings from a self-guided quit attemptAlison C McLeish, Samantha G Farris, Adrienne L Johnson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 30, 2019
Impact of omalizumab on patient-reported outcomes in chronic idiopathic urticaria: Results from a randomized study (XTEND-CIU)Thomas B Casale, Thomas R Murphy, Michael Holden, et al.
Pageof 70

Showing results (221-230 of 698) with videos related to

Sort By:
Pageof 70
Allergy and Asthma Proceedings|March 25, 2015
Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedemaKonrad Bork, Timothy J Craig, Jonathan A Bernstein, et al.
Allergy|December 16, 2020
Treatment of chronic spontaneous urticaria with benralizumab: Report of primary endpoint per-protocol analysis and exploratory endpointsJonathan A Bernstein, Umesh Singh, Marepalli B Rao, et al.
Clinical Therapeutics|March 26, 2014
The effect of weight on the efficacy and safety of C1 esterase inhibitor concentrate for the treatment of acute hereditary angioedemaJonathan A Bernstein, Thomas Machnig, Heinz-Otto Keinecke, et al.
Case Reports in Psychiatry|July 28, 2018
An Atypical Presentation of Pediatric Acute Neuropsychiatric Syndrome Responding to Plasmapheresis TreatmentDrew H Barzman, Hannah Jackson, Umesh Singh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2013
Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacksTimothy J Craig, Mikhail A Rojavin, Thomas Machnig, et al.
The New England Journal of Medicine|September 30, 2020
Benralizumab for Chronic Spontaneous UrticariaJonathan A Bernstein, Umesh Singh, Marepalli B Rao, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 7, 2024
Real-world unified airway benefits of mepolizumab: Effectiveness in patients with asthma and comorbid nasal polypsJonathan A Bernstein, Jared Silver, Elizabeth Packnett, et al.
Current Allergy and Asthma Reports|January 24, 2022
Current Needs Assessment for Using Lung Clearance Index for Asthma in Clinical PracticeIvan Cherrez-Ojeda, K Robles-Velasco, María F Osorio, et al.
Addictive Behaviors|August 10, 2016
Evaluation of smokers with and without asthma in terms of smoking cessation outcome, nicotine withdrawal symptoms, and craving: Findings from a self-guided quit attemptAlison C McLeish, Samantha G Farris, Adrienne L Johnson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 30, 2019
Impact of omalizumab on patient-reported outcomes in chronic idiopathic urticaria: Results from a randomized study (XTEND-CIU)Thomas B Casale, Thomas R Murphy, Michael Holden, et al.
Pageof 70